MarginsXMarginsX
Home › Markets › Health Care › CAH

Cardinal Health Inc. (CAH)

CAH trades on NYSE in Health Care, Other Pharmaceuticals. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$283.85
+0.98% on the day
Market cap
$65.6B
Large cap
Revenue · 2026
$254.2B
+14.2% on 2025
Net income · 2026
$1.7B
0.7% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2026-06-30, https://www.sec.gov/Archives/edgar/data/721371/000072137126000038/0000721371-26-000038-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2026-06-30.

Profile

FieldValue
TickerCAH on NYSE
SectorHealth Care
IndustryOther Pharmaceuticals
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0000721371
SEC industry codeWholesale-Drugs, Proprietaries & Druggists' Sundries
Incorporated inOH

Financials · 2026

LineValue
Revenue$254.2B
Net income$1.7B
Operating income$2.6B
Net margin0.7%
Operating margin1.0%
Revenue growth+14.2%
Cash$4.9B
Total assets$57.3B
P/E (computed)38.3×
P/S (computed)0.3×

Warning signs

Cash runway
Cash-flow positive
$5.3B cash at September 30, 2026
Share count, 1 year
-2.7%
2025-10-24 to 2026-10-31 · -6.2% over 3 years
Going-concern doubt
No
10-Q filed November 5, 2026
Insider net buying, 12 months
-$61.6M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-05
Cash and burn$5.3B cash; operating cash flow $1.1B a quarter.Report 2026-09-30
Shares outstanding231,136,655 (2026-10-31); 237,595,042 a year earlier; 246,468,133 three years earlier.Cover page 2026-10-31
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorErnst & Young LLP, Grandview Heights, Ohio, United StatesPCAOB Form AP 2026-09-08
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $61.6M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q1 2027
2026-09-30
$67.5B$554.0M$1.4B$5.3B$8.8BNeeds four quarters10-Q 2026-11-05
Q2 2026
2025-12-31
$65.6B$467.0M$686.0M$2.8B$9.0B$244.7B10-Q 2026-02-05
Q1 2026
2025-09-30
$64.0B$450.0M$973.0M$4.6B$9.0B$234.3B10-Q 2026-11-05
Q4 2025
2025-06-30
$60.2B$239.0M$1.5B$3.9B$8.5B$222.6B10-K 2026-08-11
Q3 2025
2025-03-31
$54.9B$506.0M$2.9B$3.3B$7.7B$222.3B10-Q 2025-05-01
Q2 2025
2024-12-31
$55.3B$400.0M-$396.0M$3.8B$7.6B$222.3B10-Q 2026-02-05
Q1 2025
2024-09-30
$52.3B$416.0M-$1.6B$2.9B$5.2B$224.5B10-Q 2025-10-30
Q4 2024
2024-06-30
$59.9B$235.0M$2.1B$5.1B$5.1B$226.8B10-K 2026-08-11

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52025-08-15
Latest annual report10-K2026-08-11
Latest quarterly / interim10-Q2026-11-05
Latest current report8-K2026-11-16
Latest proxy
DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS
DEFA14A2026-09-21

Source: SEC EDGAR submissions feed, 1,013 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+3.5%
1 month+17.3%
3 months+21.6%
Year to date+36.8%
1 year+36.4%
From 52-week high0.0%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Other Pharmaceuticals

TickerCompanyPriceDayMarket cap
CORCencora Inc.$356.94-0.58%$68.1B
MCKMcKesson Corporation$1105.04+0.20%$127.6B
HLFHerbalife Ltd. Common Shares$16.15+1.19%$1.7B
COSMCosmos Health Inc.$2.49-23.15%$250.6M
NUSNu Skin Enterprises Inc.$3.93-2.48%$191.3M
ZSTKZeroStack Corp.$2.80-1.75%$61.1M
ESYNEnerSyn Global Inc.$1.250.00%$37.2M
HKPDCellyan Biotechnology Co. Ltd$1.61-0.62%$4.0M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier